Ascendia Pharmaceutical Solutions services

In the intricate landscape of biopharmaceuticals, development timing is a critical factor that can significantly impact the success or failure of a drug. Saving time can mean the difference between being first to market for a new drug class or a first-to-file generic.

Ascendia offers a range of final dosage form options for our client’s development projects. Our proprietary nanotechnologies allow us to develop enabling formulations for a variety of dosage forms for small molecules and biologics, including lipid nanoparticles that encapsulate and deliver gene therapy. Our expertise and technologies also allow us to transition the new dosage forms to expand the treatment options.